Compare VKTX & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | MGEE |
|---|---|---|
| Founded | 2012 | 1855 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2014 | 2001 |
| Metric | VKTX | MGEE |
|---|---|---|
| Price | $29.62 | $74.56 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | ★ $95.86 | $80.50 |
| AVG Volume (30 Days) | ★ 1.8M | 357.6K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.41% |
| EPS Growth | N/A | ★ 11.71 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.02 |
| Revenue Next Year | N/A | $2.77 |
| P/E Ratio | ★ N/A | $56.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $72.16 |
| 52 Week High | $43.15 | $90.66 |
| Indicator | VKTX | MGEE |
|---|---|---|
| Relative Strength Index (RSI) | 42.62 | 43.78 |
| Support Level | $29.32 | $72.59 |
| Resistance Level | $36.77 | $81.89 |
| Average True Range (ATR) | 1.25 | 1.35 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 31.20 | 55.82 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
MGE Energy provides electric service to 170,000 customers and natural gas service to 180,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.